QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study 期刊论文 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 卷号: 79, 期号: 6 作者:  Wang, Zhao;  Leng, Yun;  Hou, Jian;  Jin, Jie;  Zhang, Mei 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 Recombinant human circularly permuted TRAIL  Multiple myeloma  Thalidomide  Dexamethasone  Phase 2 clinical trials   Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study 期刊论文 Cancer Chemotherapy and Pharmacology, 2017, 卷号: 79, 期号: 6, 页码: 1141-1149 作者:  Leng, Yun;  Hou, Jian;  Jin, Jie;  Zhang, Mei;  Ke, Xiaoyan 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/03 Recombinant human circularly permuted TRAIL  Multiple myeloma  Thalidomide  Dexamethasone  Phase 2 clinical trials   Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study 期刊论文 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 卷号: 79, 页码: 1141-1149 作者:  Leng, Yun;  Hou, Jian;  Jin, Jie;  Zhang, Mei;  Ke, Xiaoyan 收藏  |  浏览/下载：3/0  |  提交时间：2019/11/26 Recombinant human circularly permuted TRAIL  Phase 2 clinical trials  Dexamethasone  Multiple myeloma  Thalidomide   Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study 期刊论文 2017, 卷号: 79, 期号: 6, 页码: 1141-1149 作者:  Leng, Yun;  Hou, Jian;  Jin, Jie;  Zhang, Mei;  Ke, Xiaoyan 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 Recombinant human circularly permuted TRAIL  Multiple myeloma  Thalidomide  Dexamethasone  Phase 2 clinical trials   Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma 期刊论文 Chinese Journal of Cancer, 2016, 卷号: 第35卷, 页码: P699-705 作者:  Leng Yun;  Qiu Lugui;  Hou Jian;  Zhao Yaozhong;  Zhang Xuejun 收藏  |  浏览/下载：7/0  |  提交时间：2019/02/28 Recombinant human circularly permuted TRAIL　　Phase II trial　　Relapsed or refractory multiple myeloma　　Efficacy　　Safety   Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma 期刊论文 2016, 卷号: 35, 期号: 1, 页码: 86 作者:  Leng, Yun;  Qiu, Lugui;  Hou, Jian;  Zhao, Yaozhong;  Zhang, Xuejun 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 Recombinant human circularly permuted TRAIL  Phase II trial  Relapsed or refractory multiple myeloma  Efficacy  Safety